Gene Therapy & Cell Therapy Web Center
bioagilytix logo

Gene Therapy & Cell Therapy

Center for Education & Bioanalytical Insights

Our scientists share their expert perspectives on evolving methods and trends in cell & gene therapy bioanalysis.

Learn. Share. Discuss. Innovate Together.

Content Type
  • All Resources
  • Articles
  • Blog
  • Case Studies
  • Datasheets
  • Infographics
  • Webinars
  • All Topics
  • Bioanalytical Platforms
  • CLIA
  • Cell Therapy
  • Disease States
  • Ex Vivo
  • Gene Editing
  • Gene Therapy
  • Immunogenicity
  • In Vivo
  • Industry Insights
  • Molecular Testing
  • Oncolytic Viruses
  • Platforms
  • Vectors

What gene therapy topics interest you most?

Submit Suggestions

“Bioanalytical Strategy to Support CAR-T Therapies” Luncheon

Find Details

What are the challenges of modified & novel vehicles for gene delivery?

Find Insights

Have Specific Questions?

Ask our scientific experts – we’re ready to help.

Platform Spotlight

Need to perform immune monitoring in a regulated environment?


BioAgilytix’s ELISPOT platform is qualified and validated for regulated studies involving biologics and gene therapies.

Learn More

Did you know BioAgilytix has supported more than 20 cell and gene therapy programs?

Our proven track record means you can be confident in our deep and specialized expertise to guide your promising gene and cell therapeutics through complex bioanalytical testing phases.

Our experience in gene therapy bioanalysis spans in vivo and ex vivo studies, with specialized expertise developing robust and novel bioanalytical methods to understand the distribution, function, efficacy, and immunogenicity of innovative gene therapeutic candidates in line with regulatory requirements. We have also been successfully supporting cell therapy programs involving TIL, TCR, CAR, and other innovative modalities across a variety of delivery mechanisms and matrices for over 10 years. BioAgilytix is additionally experienced in developing bioanalytical strategies to investigate the mechanisms of oncolytic virus immunotherapies, from their antitumor properties to immune interaction effects.

We are able to offer deep GxP regulatory knowledge and proven capabilities to support these studies from preclinical phases through clinical trials and post-marketing surveillance. We leverage comprehensive expertise, a state-of-the-art platform suite, and a proven regulatory track record to efficiently progress your gene therapy or cell therapy through all phases of development – tailoring our bioanalytical package to your unique study requirements.


See Regulatory Expertise

Testing available under

Learn More


Explore Our Platforms

Available in Durham, NC, Boston, MA, and Hamburg, Germany

Learn More


Schedule a Meeting

Let’s discuss your project needs

Learn More